Received May 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMABO56A | — |
reconstituted with sterile water instead of the MenCYW-135; Menveo - Reconstitution with sterile water; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 15-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMABO56A, expiry date 31-AUG-2025) for prophylaxis. On 28-MAY-2025, the patient received Menveo. On 28-MAY-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: reconstituted with sterile water instead of the MenCYW-135) and inappropriate dose of vaccine administered (Verbatim: Menveo - Reconstitution with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-MAY-2025 A nurse reported that a patient was given a dose of Menveo (2 vial) that was reconstituted with sterile water instead of the MenCYW-135 liquid component which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The nurse asked for the recommended interval to repeat the dose. Consented to follow up.